![Vera Imper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 285 266 $ in data 31/08/2026
Vera Imper is currently an Independent Director at Cytek Biosciences, Inc., a position started in 2021.
Formerly, Dr. Imper was Vice President-Worldwide Business Development at BD Biosciences Clontech from 2009 to 2017 and Vice President & Head-Business Development at Roche Molecular Solutions from 2018 to 2021.
Education includes undergraduate, graduate, and doctorate degrees from the University of Zagreb.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 59.679 ( 0,05% ) | 285 266 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CYTEK BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 31/12/2021 |
| Società | Posizione | Fine |
|---|---|---|
BD Biosciences Clontech
 BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Corporate Officer/Principal | 01/10/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
BD Biosciences Clontech
BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Health Technology |
University of Zagreb
 University of Zagreb Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytek Biosciences, Inc.
 Cytek Biosciences, Inc. Medical SpecialtiesHealth Technology Operates as a life sciences technology company engages in the provision of cell analysis tools by leveraging novel technical approaches | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
